MRO Magazine

Research and Markets: Investigation Report on China’s Methylprednisolone Market 2010-2019

By Business Wire News   


Research and Markets ( has announced the addition of the “Investigation Report on China’s Methylprednisolone Market, 2010-2019” report to their offering.

Ever since the 1990s, steroids have entered its golden age with over 120 varieties being made for application and sales value in the global market increasing by 10%-15% each year. During the process of product restructuring and industrial development, steroid’s Active Pharmaceutical Ingredients (APIs) made in China take an important position in the global market. Out of all the varieties of steroid’s APIs, half are made in China.

As a variety performing well in hospitals in recent years, methylprednisolone, driven by clinical needs and brand effects, shows a trend of steady growth. Developed by Pharmacia & Upjohn, methylprednisolone entered China in the late 1990s under the trade names of Medrol (Pfizer) and Solu-Medrol (Pharmacia & Upjohn).

The APIs and preparations of methylprednisolone were first developed and marketed by Tianjin Tianyao Pharmaceuticals Co., Ltd in 2002. Methylprednisolone continues to grow after entering China with annual sales value rising from less than CNY 90 million in 2005 to CNY 295 million in 2014 and CAGR reaching up to 15%. Pharmacia & Upjohn (Belgium), Pharmacia & Upjohn (IT), Tianjin Tianyao Pharmaceuticals Co., Ltd, Pfizer Manufacturing Beglium NV and Rongsheng Pharmaceutical Co., Ltd all take up certain shares in the Chinese market, among which Pfizer Manufacturing Beglium NV has the largest market share of 43.7% in 2014 for sales value while Pharmia & Upjohn (IT) has the largest market share of 54.9% for sales volume.

The market size of methylprednisolone in China is expected to keep growing in the next few years.

Readers can get at the following information from this report:

– Market size of methylprednisolone in China

– Market share of manufacturers of methylprednisolone in China

– Price of methylprednisolone in Chinese market

– Major manufacturers of methylprednisolone in Chinese market

– Market outlook of methylprednisolone in China

Key Topics Covered:

1 Related Concepts of Methylprednisolone

2 Market Profile of Methylprednisolone in China

3 Survey on Sales Status of Methylprednisolone in China, 2010-2014

4 Survey on Market Share of Major Manufacturers of Methylprednisolone in China, 2010-2014

5 Survey on Dosage Forms of Methylprednisolone in China, 2010-2014

6 Reference Price of Methylprednisolone in Chinese Hospitals in 2014

7 Major Manufacturers of Methylprednisolone in Chinese Market, 2010-2014

8 Market Outlook of Methylprednisolone in China, 2015-2019

Companies Mentioned

– Rongsheng Pharmaceutical Co., Ltd

– Tianjin Tianyao Pharmaceuticals Co., Ltd

– Pharmacia & Upjohn (IT)

– Pfizer Manufacturing Beglium NV

– Tianjin Kingyork Group Co., Ltd

For more information visit

About Research and Markets

Research and Markets is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


Stories continue below

Print this page